Novel stop mutation causing familial hypercholesterolemia in a Costa Rican family
Related Experiment Video
Updated: Oct 30, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
R Thiart1, O Loubser, J N de Villiers
1Department of Human Genetics, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.
Abstract:
Combined heteroduplex single-strand conformation polymorphism (HEX-SSCP) analysis of the promoter and coding region of the low density lipoprotein receptor (LDLR) gene revealed a novel C to T mutation at nucleotide position 2056 in a Costa Rican patient with heterozygous familial hypercholesterolemia (FH). This nonsense mutation, Q665X, results in a termination codon in the epidermal growth factor (EGF) precursor homology domain of the mature LDLR.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Point and Frameshift Mutations
Pleiotropy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Animal Mitochondrial Genetics
Mutations
